Related Experiment Video
Updated: Aug 9, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Patients misrepresenting their risk factors for AIDS
International Journal of STD & AIDS
|November 1, 1995
Summary
Patients often misreport sexual and drug use history in HIV/AIDS studies. This underreporting may inflate estimates of HIV vaginal transmission risk, necessitating improved methods to assess self-report validity in research.
Area of Science:
- Medical Research
- Epidemiology
- Behavioral Science
Background:
- Studies on human immunodeficiency virus (HIV) transmission and acquired immunodeficiency syndrome (AIDS) risk factors rely on patient self-reports.
- Assessing the accuracy of self-reported sexual and drug use histories is crucial for understanding HIV transmission dynamics.
Discussion:
- Evidence suggests significant underreporting of risk factors like anal intercourse and intravenous drug use.
- This misrepresentation can lead to inflated estimates of HIV vaginal transmission risk, particularly in industrialized nations.
- Understanding the motivations behind such misreporting, both normal and pathological, is essential.
Key Insights:
- Self-reports of sexual and drug use in HIV/AIDS research may not be fully truthful.
- Underreporting of specific behaviors suggests a potential overestimation of certain HIV transmission routes.
- Validating self-reported data is critical for accurate risk assessment.
Outlook:
- Future HIV/AIDS behavioral research requires advanced methods to ensure self-report validity.
- Implementing behavioral markers, enhanced lie scales, and physical assessment methods are recommended.
- Improving data accuracy will lead to more reliable HIV transmission risk estimates and targeted prevention strategies.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...